BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 5109264)

  • 1. [Pharmacology of catatonigenic agents. 5. The effect of neuroleptics].
    Stille G
    Arzneimittelforschung; 1971 Jun; 21(6):800-8. PubMed ID: 5109264
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pharmacology of catatonigenic substances. 6. Conclusion].
    Stille G
    Arzneimittelforschung; 1971 Jul; 21(7):997-1003. PubMed ID: 5109518
    [No Abstract]   [Full Text] [Related]  

  • 3. [The antipsychotic action of neuroleptics and basal ganglia function].
    Arushanian EB
    Farmakol Toksikol; 1973; 26(4):481-9. PubMed ID: 4151298
    [No Abstract]   [Full Text] [Related]  

  • 4. [Pharmacology of catatonigenic drugs. 2. Elimination of the N. caudatus and the catatonigenic effects of neuroleptics].
    Stille G
    Arzneimittelforschung; 1971 Mar; 21(3):386-90. PubMed ID: 5107977
    [No Abstract]   [Full Text] [Related]  

  • 5. Neurophysiological substrates of the pharmacological criteria for neuroleptics.
    Stille G
    Mod Probl Pharmacopsychiatry; 1970; 5():56-60. PubMed ID: 5527169
    [No Abstract]   [Full Text] [Related]  

  • 6. [Neuropharmacological findings after chronic administration of haloperidol, loxapine and clozapine].
    Sayers AC; Kleinlogel H
    Arzneimittelforschung; 1974 Jul; 24(7):981-3. PubMed ID: 4408075
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of neuroleptic agents in the chronic pharmacological experiment].
    Stille G; Lauener H
    Arzneimittelforschung; 1974 Sep; 24(9):1292-4. PubMed ID: 4479794
    [No Abstract]   [Full Text] [Related]  

  • 8. [Pharmacology of catatonigenic drugs. 3. The effect of bulbocapnin].
    Stille G
    Arzneimittelforschung; 1971 Apr; 21(4):528-35. PubMed ID: 5108156
    [No Abstract]   [Full Text] [Related]  

  • 9. [Neurophysiologic study of the psychomotor effect of a drug: apropos of bulcocapnine catatonia].
    Borenstein P; Gekière F; Aleonard P; Gruet-Masson J; Allègre G
    Sem Hop; 1969 Apr; 45(19):1247-57. PubMed ID: 4306997
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of a striatal spreading depression on the pharmacogenic catatonia.
    Stille G; Sayers A
    Int J Neuropharmacol; 1969 Mar; 8(2):181-9. PubMed ID: 5814587
    [No Abstract]   [Full Text] [Related]  

  • 11. [Farnesol and neuroleptics. I. Reinforcement by farnesol of the experimental cataleptigenic effect of neuroleptics].
    Binet P; Miocque M; Roux M; Rinjard P
    Ann Pharm Fr; 1975 May; 33(5):229-34. PubMed ID: 1239975
    [No Abstract]   [Full Text] [Related]  

  • 12. Neuroleptic and non-neuroleptic catalepsy.
    Costall B; Naylor RJ
    Arzneimittelforschung; 1973 May; 23(5):674-83. PubMed ID: 4740210
    [No Abstract]   [Full Text] [Related]  

  • 13. On the pharmacology of benzquinamide.
    Kadzielawa K; Gumulka W
    Arch Int Pharmacodyn Ther; 1966 Sep; 163(1):139-48. PubMed ID: 6013214
    [No Abstract]   [Full Text] [Related]  

  • 14. [Comparative evaluation of some antidepressants by their action on the effect of benzquinamide and tetrabenazine].
    Vikhliaev IuI; Lakoza GN
    Farmakol Toksikol; 1969; 32(5):522-6. PubMed ID: 5395561
    [No Abstract]   [Full Text] [Related]  

  • 15. [Arousal inhibiting and catalepsy in neuroleptic drugs].
    Stille G
    Arzneimittelforschung; 1966 Feb; 16(2):255-6. PubMed ID: 6013811
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacological properties of a new potential neuroleptic drug oxyprothepin. 3. Electroencephalographic study in rabbits.
    Likovský Z; Votava Z
    Act Nerv Super (Praha); 1971; 13(3):187-8. PubMed ID: 5113832
    [No Abstract]   [Full Text] [Related]  

  • 17. [Nonuniform effect of cataleptogenic and atypical neuroleptics on the turning reactions induced by stimulation of the putamen and caudate nucleus in cats].
    Anokhov SS; Arushanian EB
    Farmakol Toksikol; 1984; 47(6):16-20. PubMed ID: 6151517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Electroencephalographic analysis of the central action of benzonal].
    Saratikov AS; Naĭdenova MI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1983; 83(6):873-6. PubMed ID: 6880518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prediction of sedative potency of neuroleptics.
    Loew DM
    Mod Probl Pharmacopsychiatry; 1970; 5():47-50. PubMed ID: 5527167
    [No Abstract]   [Full Text] [Related]  

  • 20. Central excitatory effects of delta 1- and delta 6-tetrahydrocannabinol.
    Segal M; Asscher Y
    Isr J Med Sci; 1973; 9 Suppl():31-42. PubMed ID: 10189870
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.